You may also like
Bedside Allogeneic Erythrocyte Washing with a Cell Saver to Remove Cytokines, Chemokines, and Cell-derived Microvesicles: A Clinical Feasibility Study
Bedside erythrocyte washing was clinically feasible and greatly reduced concentrations of soluble factors thought to be associated with transfusion-related adverse reactions, increasing concentrations of cell-free hemoglobin while maintaining acceptable (less than 0.8%) hemolysis.
1 min read
Transapical AVR in the Hybrid OR Setting (EP Video)
Dr. Alan Heldman discusses transapical aortic valve replacement in the hybrid OR setting (45:34 minutes).
1 min read
Does Stark Phase III Ring the Death Knell for Physician-Owned Perfusion Groups?
The Stark Law, and the rules and regulations promulgated there under, is administered by the Department of Health and Human Services, Centers for Medicare and Medicaid Services (CMS). Unless there is a specific exemption contained in the law or regulations, a physician cannot refer a Medicare patient for “designated health services” (those listed in the law or regulations) to an entity in which the physician or an immediate family member has a financial relationship.
5 min read